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Abstract
Context: Whether a healthy lifestyle may be associated with longer telomere length is largely unknown.
Objectives: To examine healthy lifestyle practices, which are primary prevention measures against major age-related
chronic diseases, in relation to leukocyte telomere length.
Design and Setting: Cross-sectional analysis in the Nurses’ Health Study (NHS).
Participants: The population consisted of 5,862 women who participated in multiple prospective case-control studies
within the NHS cohort. Z scores of leukocyte telomere length were derived within each case-control study. Based on prior
work, we defined low-risk or healthy categories for five major modifiable factors assessed in 1988 or 1990: non-current
smoking, maintaining a healthy body weight (body mass index in 18.5–24.9 kg/m
2), engaging in regular moderate or
vigorous physical activities ($150 minutes/week), drinking alcohol in moderation (1 drink/week to ,2 drinks/day), and
eating a healthy diet (Alternate Healthy Eating Index score in top 50%). We calculated difference (%) of the z scores
contrasting low-risk groups with reference groups to evaluate the association of interest.
Results: Although none of the individual low-risk factors was significantly associated with larger leukocyte telomere length z
scores, we observed a significant, positive relationship between the number of low-risk factors and the z scores. In
comparison with women who had zero low-risk factors (1.9% of the total population) and were, therefore, considered the
least healthy group, the leukocyte telomere length z scores were 16.4%, 22.1%, 28.7%, 22.6%, and 31.2% (P for
trend=0.015) higher for women who had 1 to 5 low-risk factors, respectively.
Conclusions: Adherence to a healthy lifestyle, defined by major modifiable risk factors, was associated with longer telomere
length in leukocytes.
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Introduction
The risk of developing many major chronic diseases, including
cardiovascular disease (CVD), cancer, and type 2 diabetes, rises
substantially with age. However, the risk of developing these
diseases varies considerably for individuals of the same age,
suggesting the hypothesis that ‘‘biological aging’’ rather than
‘‘chronological aging’’ may be the more important component of
the increasing risks across the life span. Accumulating evidence
suggests that the attrition of telomeres, special chromatin
structures that cap the ends of eukaryotic chromosomes and
maintain genome stability [1,2], may reflect biological aging. At
the cellular level, progressive loss of telomeric DNA eventually
leads to cell death or senescence [3,4,5], and may subsequently
contribute to the increased risk of developing age-related chronic
conditions [6,7,8,9].
Interestingly, at the population level, studies have suggested that
the telomere attrition is likely a modifiable factor as there is
substantial variability in the rate of telomere shortening that is
independent of chronological age. Such telomere length variability
may be partially explained by lifestyle practices [10]. Meanwhile,
a growing literature has consistently shown that a substantial
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38374proportion of chronic diseases, including coronary heart disease,
stroke, diabetes, as well as early mortality, may be attributable to
failing to adopt a composite healthy lifestyle that combines
multiple low-risk factors, including non-smoking, regular physical
activity, a healthy diet, maintaining a healthy body weight, and
light-to-moderate alcohol consumption [11,12,13,14,15,16,17,18].
More importantly, all of these studies have demonstrated that the
joint effects of multiple low-risk factors are much more pro-
nounced than the effect of any single factor. However, few studies
[19] have been conducted to examine the association of
a combination of low-risk lifestyle factors with telomere length,
which may potentially explain the protective effects of healthy
lifestyle on age-related health conditions.
We, therefore, took advantage of the rich data collected in the
Nurses’ Health Study (NHS) cohort to explicitly evaluate
combinations of low-risk, healthy lifestyle practices in relation to
leukocyte telomere length (LTL) in women at midlife, a life-stage
at considerable risk of developing chronic diseases [20,21,22].
Methods
Study Population
The NHS was established in 1976 when 121,700 female
registered nurses aged 30–55 years were enrolled through
a questionnaire inquiring about history of chronic diseases and
demographic and lifestyle characteristics. Since baseline, follow-up
questionnaires had been administered every two years to update
the information of disease incidence, lifestyle practices, and clinical
risk factors. In the NHS, self-reports of major chronic diseases
(such as cancer, diabetes, coronary heart disease, and stroke) were
confirmed by study physicians through medical record review,
pathology report review, telephone interview, or supplementary
questionnaire inquiries [23,24,25]. Deaths were identified by
reports from next of kin, postal authorities, or by a search of the
National Death Index. At least 98% of deaths among the NHS
participants were identified [26]. Through 2002, follow-up rates
have exceeded 95%.
In 1989–1990, 32,826 participants provided blood samples [27],
which were immediately processed upon arrival and aliquoted into
cryotubes as plasma, buffy coat, and red blood cells. Among this
cohort, multiple prospective nested case-control studies of cancers
and CVD were conducted [28,29,30]. All of these case-control
studies used the same design: for each incident case of a disease,
a risk-set sampling scheme was used to select one to three controls
from the remaining participants in the blood sub-cohort who were
free of that disease when the case was diagnosed. All cases and
controls were free of the specific disease of interest in each
individual study when blood was drawn. In addition, cases and
controls were matched for menopausal status and postmenopausal
hormone use (except for the myocardial infarction case-control
study), age, and time of blood draw, as well as other factors that
were carefully chosen for each individual study. In addition to
these case-control studies, telomere length data were also available
in a study of cognitive function [31]. In total, the current analysis
included data of 7,116 participants from nine studies (myocardial
infarction, stroke, cognitive function, breast cancer, endometrial
cancer, pancreatic cancer, and three skin cancer studies), in which
LTL was measured. In published data based on some of these
studies, shorter telomere length was not significantly associated
with cancer risks [28,29,30], but weakly correlated with more
cognitive decline [31].
The study protocol was approved by the institutional review
board of the Brigham and Women’s Hospital and the Human
Subjects Committee Review Board of Harvard School of Public
Health. Written informed consent was obtained from all
participants.
Measurement of Leukocyte Telomere Length
All buffy-coat cryotubes were stored in the vapor phase of liquid
nitrogen freezers at #2130uC. Genomic DNA was extracted from
buffy coat fractions using the QIAmp (Qiagen, Chatsworth, CA)
96-spin blood protocol. A pico-green quantitation using a Molec-
ular Devices 96-well spectrophotometer was used and results were
confirmed by using a Nanodrop SD-1000 spectrophotometer.
Subsequent standardization by drying down the genomic DNA
and re-suspending ensured accurate and uniform DNA concen-
trations. For all 9 studies, DNA was extracted at the same lab and
then stored in freezers at #280uC. Of these 9 studies that
contributed to the current analysis, telomere length was measured
within a month after DNA was extracted for 4 studies. This time
lag was within 1 year for 3 studies or 2–4 years for the rest 2
studies.
Relative average LTL was assessed by a modified high-
throughput version [32] of the real-time PCR-based telomere
assay developed by Cawthon et al [33]. In this assay, the ratio of
telomere repeat copy number to single-copy gene copy number
(T:S ratio) was derived and the relative LTL was measured as the
exponentiated T:S ratio. All samples for both the telomere and
single-copy gene (ribosomal protein, large, P0; RPLP0) reactions
were processed in triplicate. Technicians and laboratory personnel
were blinded as to the disease status of the participants. Samples
were assayed by the same technicians in a random sequence under
identical conditions. In each contributing study, we included 10%
quality-control (QC) samples in each batch, and each QC sample
was evenly split into halves. Based on the repeated measurements
of these QC samples, we calculated the coefficient of variation
(CV) to evaluate the performance of telomere length assays. The
CVs ranged from 0.2% to 3.1% for the single-copy gene assay,
0.6% to 2.1% for the telomere assay, and 10.8 to 16.0% for the
exponentiated T:S ratio. Because telomere length was assayed
during 2007–2010 for the 9 studies in various batches, in the
current analysis, to minimize the impact of potential batch shift on
LTL measurements across different studies, we log-transformed
the LTL and then calculated a z score of LTL by standardizing the
LTL in comparison to the mean within each individual study [34].
Assessment of Lifestyle Practices
Beginning in 1976, the NHS has collected and updated
biennially the information on a wide array of demographic and
lifestyle risk factors, including detailed history of cigarette smoking,
family history of chronic diseases, personal medical history, and
use of aspirin. Body weight and height were self-reported with high
accuracy [35]. Body mass index (BMI) was calculated as weight in
kilograms divided by the square of height in meters (kg/m
2)t o
estimate overall adiposity. In 1988, a validated questionnaire [36]
for physical activity was embedded into the follow-up question-
naire to evaluate the average time per week in the past year spent
on leisure-time physical activities including walking or hiking
outdoors, bicycling, lap swimming, tennis, and calisthenics/
aerobics/aerobic dance/rowing machine. For each question, there
were 10 possible coding responses, ranging from ‘‘zero’’ to ‘‘11+
hours/week’’. We further inquired about the usual walking pace of
NHS participants; coding responses included easy (,2 miles/hour
[MPH]), normal (2.0–2.9 MPH), brisk (3.0–3.9 MPH), and very
brisk ($4.0 MPH). Walking at a brisk or very brisk pace was
considered as a moderate physical activity while jogging, running,
bicycling, swimming, tennis, and aerobics activities were consid-
ered as vigorous physical activities.
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naire (FFQ) was sent to NHS participants to assess their diet in the
past year. In 1984, 1986, and every 4 years thereafter, an
expanded FFQ containing 116–130 food items was sent to the
NHS participants to update their diet. In these FFQs, we inquired
about the frequency of consuming each food item of a pre-
specified standard portion size. The validity of these FFQs was
documented in previous studies [37]. To summarize the overall
quality of diet, we created the Alternate Healthy Eating Index
(AHEI), which was based on the U.S. Department of Agriculture
Healthy Eating Index [38]. Briefly, the AHEI index summarized
higher intakes of vegetables, fruit, nuts, soy, and cereal fiber,
higher ratios of chicken plus fish to red meat and polyunsaturated
to saturated fat, lower intake of trans fat; and multivitamin use of
$5 years. Possible values of the AHEI index ranged from 2.5
(worst) to 77.5 (best). For each alcoholic beverage, a standard
portion size (1 glass/bottle/can for beer, 4 oz. glass for wine, and 1
drink/shot for liquor) was specified and the participants were
asked how often, on average, they consumed the alcoholic
beverage of that specified amount. There were nine possible
coding responses, ranging from ‘‘never or less than once per
month’’ to ‘‘six or more times per day’’. Frequency of alcohol
consumption was derived by summing up the frequency of
consumption for each individual alcoholic beverage type.
Definition of Healthy Lifestyle Pattern
A healthy lifestyle was defined using five components including
smoking, physical activity, adiposity, alcohol use, and diet. For
each factor, we created a binary low-risk or healthy variable,
defined as non-current smoking, 18.5 kg/m
2#BMI,25.0 kg/m
2,
moderate or vigorous physical activities $150 minutes/week [39],
moderate alcohol consumption (1 drink/week to ,2 drinks/day),
and AHEI score in top 50%, respectively. Similar definitions of
healthy lifestyle pattern were used in previous analyses in the NHS
cohort [12,13,17]. The assessments of these variables were based
on 1990 questionnaire, except physical activity which was assessed
in 1988 questionnaire.
The associations between healthy lifestyles and multiple chronic
diseases have been well documented in previous studies
[12,13,14,15,17,18]. For example, in comparison to men or
women with no low-risk factors, those who adhered to healthy
lifestyle patterns comprised of multiple low-risk lifestyle and
dietary factors had 84% lower risk of coronary heart disease [13],
69% to 81% lower risk of total or ischemic strokes [17], 52% lower
risk of heart failure [15], 91% lower risk of type 2 diabetes [12],
and 62% to 65% lower mortality rate [14,18].
Exclusion Criteria
In the current analysis, we included both cases and controls to
maximize our statistical power. We applied two exclusion criteria.
First, to minimize confounding by existing chronic diseases on the
associations of interest, we excluded 637 participants who were
diagnosed with heart disease, stroke, diabetes, and cancers prior to
blood draw. Second, we excluded 617 participants who had
missing values for any of the 5 lifestyle or dietary variables. After
these two exclusions, a total of 5,862 (82.4% of total eligible
participants) women were included in the current analysis.
Statistical Analysis
We calculated Spearman correlation coefficients of LTL z score
with age and lifestyle factors. To estimate potential dose-response
relationship between LTL z score and the combinations of low-risk
factors, we used generalized linear regression to calculate least-
square (LS) means of LTL z score by levels or categories of lifestyle
factors. These LS means were adjusted for age at blood draw and
its quadratic term, postmenopausal status (yes, no), postmeno-
pausal hormone therapy (never, past, current), use of aspirin (,1
tablet/wk, 1–2 tablet/wk, 3–6 tablet/wk, 7–14 tablet/wk, 15+
tablet/wk), family history of myocardial infarction, diabetes, or
cancer (yes, no), and the case-control status in the contributing
studies to control for confounding. Since z scores of relative LTL
may be difficult to interpret, we further calculated the relative
difference (% of difference) for each category in comparison with
a reference group. This analysis was conducted using a macro,
%Robreg9 (available on request), which calculates point estimates
and empirical standard errors of effect on the unitless percent
change scale in robust linear regression models when the
dependent variable is on the log scale [40,41]. More details for
this method were introduced at the Methods S1. To estimate P for
linear trend between the number of low-risk factors and telomere
length z score, we entered an ordinal score (0 to 5, corresponding
to the number of the factors) into the multivariate models.
All P values are two-sided. Ninety-five percent confidence
intervals (95% CI) were calculated for ORs. Data were analyzed
with the Statistical Analysis Systems software package, version 9.1
(SAS Institute, Inc., Cary, North Carolina).
Results
Primary Analysis
TABLE 1 shows the baseline characteristics of the study
participants in comparison with the rest of NHS cohort who did
not meet the exclusion criteria set for the current analysis, as well
as with those who were excluded following the exclusion criteria.
Because age, postmenopausal status and hormone use were
matching factors for most of the contributing case-control studies,
our study participants were slightly older and more likely to use
hormone therapy after menopause than the rest of NHS cohort.
Otherwise, we observed largely similar distributions of lifestyle and
dietary factors between these two groups after age-standardization.
Distributions of family history of major diseases were slightly
different between these two groups, although no consistent pattern
was observed. In contrast, the excluded participants tended to
have a less optimal distribution of low-risk factors. For example,
excluded participants were heavier, less physically active, and
more likely to be smokers and had a lower AHEI score in
comparison with the other two groups, whereas all three groups
had the same levels of alcohol consumption. In addition, the cases
and controls who were selected for the original case-control studies
had similar distribution of these factors (TABLE S1).
We calculated Spearman correlation coefficients (rs) between
LTL z score and age and the modifiable factors of interest. As
expected, we observed a significant, inverse correlation
(rs=20.10, P,0.0001) for age. After controlling for age, we
observed a weak correlation for smoking status (rs=20.03,
P=0.03), whereas there were no correlations for BMI
(rs=20.02, P=0.15), physical activity (rs=0.02, P=0.18), alcohol
consumption (rs=0.001, P=0.93), and AHEI score (rs=0.02,
P=0.09). Similar patterns of association were found when
modeling these data categorically (TABLE 2). None of these
individual comparisons reached statistical significance in multi-
variate analyses, except smoking status and AHEI score. In
comparison with current smokers, women who never smoked had
an 8.0% (95% CI: 0.5%, 16.7%) higher LTL z scores. This figure
was 7.3% (95% CI: 0.0%, 15.2%) comparing the 3
rd AHEI
quartile with the lowest quartile. After mutual adjustment for other
lifestyle and dietary factors, these associations were attenuated to
7.6% (95% CI: 20.4%, 16.2%) for smoking and 6.1% (95% CI:
Lifestyle and Telomere Length
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remained non-significant after mutual adjustments.
In a separate analysis, we evaluated LTL z score between the
optimal low-risk group and all other women for each modifiable
factor. Similarly, none of the individual factors were associated
with longer telomere length (TABLE 3). After adjustment for
covariates, including mutual adjustment of the other lifestyle
factors, women who were not current smokers had a 5.2% (95%
CI: 22.1%, 13.1%) higher LTL z scores than all other women.
The relative difference was 3.6% (95% CI: 21.7%, 9.2%) for BMI
(between 18.5 and 24.9 kg/m
2 vs. other), 3.4% (95% CI: 22.2%,
9.2%) for physical activity ($150 minutes/week vs. other), 3.3%
(95% CI: 22.0%, 8.9%) for AHEI score (top 50% vs. bottom
50%), and 20.9% (95% CI: 25.9%, 4.4%) for alcohol use
(between 1 drink/week to ,2 drinks/day vs. other).
Subsequently, we examined the association between the total
number of low-risk factors and LTL z score (FIGURE 1 and
TABLE S2). Of 5862 participants, 1.9% had no low-risk factors,
i.e., they constituted the least healthy group. The proportions of
women who had only 1 to all 5 (the most healthy group) low-risk
factors were 13.7%, 27.2%, 30.0%, 20.4%, and 6.8%, re-
spectively. We observed increased LTL z scores with increasing
number of low-risk factors. In comparison to women who had no
low-risk factors, women who had 1 to 5 low-risk factors had 16.4%
(95% CI: 24.0%, 41.2%), 22.1% (95% CI: 1.2%, 47.3%), 28.7%
(95% CI: 6.6%, 55.3%), 22.6% (95% CI: 1.4%, 48.3%), and
31.2% (95% CI: 6.6%, 61.5%; P for trend=0.015) higher LTL z
score, respectively.
Secondary Analysis
In a secondary analysis, we examined the robustness of these
associations by excluding studies for which DNA was extracted
more than 1 year before telomere length assay. When we excluded
the breast cancer study that had DNA extracted 4 years before
telomere assay, we observed similar associations: in comparison
with participants who had no low-risk factors, the LTL z score was
12.3%, 19.2%, 28.2%, 20.2%, and 27.2% (95% CI: 1.1%, 61.3%;
P for trend=0.02) higher for women who had 1 to 5 low-risk
factors. These figures were 11.0%, 17.6%, 26.5%, 19.0%, and
26.3% (95% CI: 20.3%, 59.9%; P for trend=0.02) after
melanoma study (the time lag between DNA extraction and
telomere length assay was 2 years) was further excluded.
Furthermore, we also examined the associations within 3,580
controls to evaluate the robustness of the results. We observed
largely similar associations within the controls only, although most
of these associations did not reach statistical significance likely due
Table 1. Baseline characteristics* of the study participants in the current analysis in comparison with the rest of Nurses’ Health
Study participants, 1990.
Variables Study participants NHS cohort{ Excluded participants{
N 5862 52884 50765
Age (year) 58.760.09 56.060.03 57.360.03
BMI (kg/m
2) 25.260.3 25.560.3 26.360.3
Moderate to vigorous physical activity (minutes/week)1 135.0611.9 126.2611.8 111.8611.2
Smoking status (%)
Never smoked 43.6 44.8 41.6
Past smoker 41.3 39.2 37.2
Current smoker 15.2 16.0 21.1
Alcohol intake (drink/day) 0.460.04 0.460.04 0.460.04
AHEI diet score 39.660.5 38.660.5 38.160.5
Postmenopausal status (%)
Premenopausal 21.5 26.5 28.0
Never used HRT 23.4 29.4 29.5
HRT past user 13.3 16.3 18.5
HRT current user 41.8 27.8 24.0
Use of aspirin (%)
,1 tablet/wk 35.5 37.2 38.4
1–6 tablet/wk 48.7 47.1 45.5
7+ tablet/wk 15.8 15.7 16.1
Family history of myocardial infarction (%) 18.6 19.0 19.2
Family history of diabetes (%) 26.7 26.1 21.9
Family history of cancer (%) 16.4 14.0 10.8
Abbreviations: NHS, the Nurses’ Health Study; BMI, body mass index; HRT, hormone replacement therapy; AHEI, alternate healthy eating index.
*Values were age-adjusted mean6SE for continuous variables or age-adjusted proportion for categorical variables, except age per se.
{The same exclusion criteria were applied to the rest NHS participants. Therefore, this group was primarily consisted of participants who responded to 1990 FFQ.
{Excluded by two reasons, i.e., missing values of low-risk factors (83.2%) due to non-response to 1988 or 1990 follow-up questionnaires and development of prevalent
chronic diseases at baseline (16.8%).
1Assessed by 1988 questionnaire. Moderate physical activities included walking at a brisk (3.0–3.9 MPH) or very brisk ($4.0 MPH) pace. Vigorous physical activities
included jogging ($10 min/mile), running (,10 min/mile), bicycling, lap swimming, tennis, and calisthenics/aerobics/aerobic dance/rowing machine. All other variables
were assessed using the 1990 questionnaire, which was administered primarily during blood collection.
doi:10.1371/journal.pone.0038374.t001
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comparison with participants who had no low-risk factors, the
LTL z score was 9.8%, 9.6%, 15.0%, 17.0%, and 28.1% (95% CI:
22.8%, 68.7%; P for trend=0.017) higher for women who had 1
to 5 low-risk factors. In a separate analysis, we excluded alcohol
consumption from the low-risk factors and repeated the analysis to
be comparable with the only prior study that was conducted in
men [19]. In this analysis, in comparison with women who had
zero low-risk factors, women who had 1–4 low-risk factors had
21.2%, 25.1%, 31.5%, and 28.1% (95% CI: 9.6%, 49.7%; P for
trend=0.003) higher LTL z score, respectively. Lastly, we
evaluated the correlation among the 5 low-risk factors in our
study population (TABLE S3). Most of these pair-wise associations
were highly significant, corroborating the inter-correlation among
these lifestyle and dietary factors. Exceptions were only found
between moderate drinking and non-smoking or healthy diet.
Discussion
In these middle-aged U.S. women who were generally healthy
at baseline, optimal lifestyle practices, defined by five low-risk,
healthy lifestyle factors for chronic disease (non-current smoking,
engaging in regular moderate to vigorous physical activity,
maintaining an optimal body weight, eating a healthy diet, and
consuming alcohol in moderation), were significantly associated
with longer LTL. Although each individual low-risk factor was
associated with longer LTL only weakly, the combined effect of
these low-risk factors was much stronger than that of any single
factor.
Results in relation to other studies
Associations between lifestyle and dietary factors and LTL have
been examined previously, but the results have been inconsistent.
Table 2. Multivariate-adjusted least-squares (LS) means of z score of leukocyte telomere length (LTL) and relative LTL difference by
categories of modifiable risk factors in women.
Risk factors n (%) Model 1
* Model 2
{
LS means (SE) % Difference
{ (95% CI) LS means (SE) % Difference
{ (95% CI)
Smoking status
Never smoked 2591 (44.2) 0.043 (0.020) 8.0% (0.5%, 16.7%) 0.044 (0.020) 7.6% (20.4%, 16.2%)
Past smoker 2425 (41.4) 0.004 (0.020) 4.1% (23.5%, 12.3%) 0.001 (0.020) 2.9% (24.8%, 11.2%)
Current smoker 846 (14.4) 20.036 (0.034) Reference 20.029 (0.035) Reference
Body mass index (kg/m
2)
,18.5 72 (1.2) 20.085 (0.117) 25.7% (225.1%, 18.7%) 20.084 (0.118) 26.2% (225.4%, 18.1%)
18.5–24.9 3288 (56.1) 0.033 (0.017) 6.1% (22.2%, 15.1%) 0.031 (0.018) 5.3% (23.1%, 14.4%)
25.0–29.9 1753 (29.9) 0.005 (0.024) 3.2% (25.4%, 12.5%) 0.006 (0.024) 2.6% (25.9%, 12.0%)
$30 749 (12.8) 20.026 (0.037) Reference 20.021 (0.037) Reference
Moderate to vigorous physical activity
(minutes/week)
$150 2072 (35.4) 0.045 (0.022) 6.2% (20.5%, 13.3%) 0.037 (0.022) 4.3% (22.4%, 11.5%)
60–149 1000 (17.1) 0.016 (0.031) 3.1% (24.6%, 11.4%) 0.015 (0.032) 2.0% (25.6%, 10.2%)
,60 1069 (18.2) 0.005 (0.030) 2.0% (25.4%, 10.0%) 0.007 (0.031) 1.2% (26.2%, 9.1%)
0 1721 (29.4) 20.015 (0.024) Reference 20.005 (0.024) Reference
AHEI diet score
" (range)
Quartile 4 (46.6–73.2) 1465 (25.0) 0.036 (0.026) 6.8% (20.6%, 14.7%) 0.027 (0.027) 5.0% (22.6%, 13.1%)
Quartile 3 (39.9–46.6) 1467 (25.0) 0.041 (0.026) 7.3% (0.0%, 15.2%) 0.037 (0.026) 6.1% (21.3%, 14.1%)
Quartile 2 (33.5–39.8) 1465 (25.0) 0.015 (0.026) 4.6% (22.7%, 12.5%) 0.019 (0.026) 4.2% (23.2%, 12.1%)
Quartile 1 (9.1–33.4) 1465 (25.0) 20.030 (0.026) Reference 20.022 (0.027) Reference
Alcohol use
$2 drinks/day 348 (5.9) 0.054 (0.053) 3.9% (26.3%, 15.3%) 0.067 (0.054) 5.4% (25.2%, 17.2%)
1 drink/week to ,2 drinks/day 2744 (46.8) 0.012 (0.019) 20.3% (25.9%, 5.5%) 0.011 (0.019) 20.3% (26.0%, 5.7%)
,1 drink/week 663 (11.3) 0.012 (0.039) 20.4% (28.6%, 8.6%) 0.012 (0.039) 20.2% (28.5%, 8.7%)
Non-user 2107 (35.9) 0.015 (0.022) Reference 0.014 (0.022) Reference
*Model 1 was adjusted for age at blood draw and its quadratic term, postmenopausal status (yes, no), hormone replacement therapy (never, past, current), use of aspirin
(,1 tablet/wk, 1–2 tablet/wk, 3–6 tablet/wk, 7–14 tablet/wk, 15+ tablet/wk), case-control status in each original studies (yes, no), and family history of myocardial
infarction, diabetes, or cancer (yes, no).
{Based on model 1, these modifiable risk factors were mutually adjusted for, i.e., we mutually controlled for smoking status (never smoked, past smoker, or current
smoker), body mass index (,18.5 kg/m
2, 18.5–24.9 kg/m
2, 25.0–29.9 kg/m
2,o r$30 kg/m
2), moderate to vigorous physical activity ($150 minutes/week, 60–
149 minutes/week, ,60 minutes/week, or 0 minutes/week), AHEI diet score (in quartiles), and alcohol use ($2 drinks/day, 1 drink/week to ,2 drinks/day, ,1 drink/
week, or non-user).
{% Difference measures the change of standardized LTL for each category in proportion to the standardized LTL of the reference category for each factor after
multivariate adjustment.
"AHEI diet score summarized intakes of trans fat, polyunsaturated to saturated fat ratio, ratio of chicken and fish to red meat, fruits, vegetables, soy, nuts, cereal fiber,
and multivitamin use.
doi:10.1371/journal.pone.0038374.t002
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low vs. high risk groups for each modifiable risk factor in women.
Risk factors n(%) Model 1
* Model 2
{
LS means (SE) % Difference
{ (95% CI) LS means (SE) % Difference
{ (95% CI)
Smoking status
Non-current smoking 5016 (85.6) 0.024 (0.014) 6.2% (20.9%, 13.9%) 0.023 (0.014) 5.2% (22.1%, 13.1%)
All other women 846 (14.4) 20.036 (0.034) Reference 20.028 (0.035) Reference
Body mass index
18.5–24.9 kg/m
2 3288 (56.1) 0.033 (0.017) 4.0% (21.2%, 9.6%) 0.031 (0.018) 3.6% (21.7%, 9.2%)
All other women 2574 (43.9) 20.007 (0.020) Reference 20.004 (0.020) Reference
Moderate to vigorous physical activity
$150 minutes/week 2072 (35.4) 0.045 (0.022) 4.7% (20.7%, 10.5%) 0.037 (0.022) 3.4% (22.2%, 9.2%)
All other women 3790 (64.7) 20.001 (0.016) Reference 0.004 (0.016) Reference
Diet
AHEI score
" in top 50% 2932(50.0) 0.038 (0.018) 4.6% (20.6%, 10.1%) 0.032 (0.019) 3.3% (22.0%, 8.9%)
All other women 2930 (50.0) 20.007 (0.018) Reference 20.001 (0.019) Reference
Alcohol use
1 drink/week to ,2 drinks/day 2744 (46.8) 0.012 (0.019) 20.7% (25.7%, 4.5%) 0.011 (0.019) 20.9% (25.9%, 4.4%)
All other women 3118 (53.2) 0.019 (0.018) Reference 0.020 (0.018) Reference
*Model 1 was adjusted for the same set of covariates in model 1, Table 2.
{Based on model 1, these modifiable risk factors were mutually adjusted for, i.e., we mutually controlled for smoking status (never smoked, past smoker, or current
smoker), body mass index (,18.5 kg/m
2, 18.5–24.9 kg/m
2, 25.0–29.9 kg/m
2,o r$30 kg/m
2), moderate to vigorous physical activity ($150 minutes/week, 60–
149 minutes/week, ,60 minutes/week, or 0 minutes/week), AHEI diet score (in quartiles), and alcohol use ($2 drinks/day, 1 drink/week to ,2 drinks/day, ,1 drink/
week, or non-user).
{% Difference measures the change of standardized LTL for each category in proportion to the standardized LTL of the reference category for each factor after
multivariate adjustment.
"AHEI diet score summarized intakes of trans fat, polyunsaturated to saturated fat ratio, ratio of chicken and fish to red meat, fruits, vegetables, soy, nuts, cereal fiber,
and multivitamin use.
doi:10.1371/journal.pone.0038374.t003
Figure 1. LS means of leukocyte telomere length z scores by numbers of low-risk lifestyle practices. Least-square means were adjusted
for the same set of covariates for model 1 in Table 2. Low-risk group for each lifestyle factor was defined as non-current smoking, moderate alcohol
use (1 drink/week to ,2 drinks/day), a healthy body weight (18.5 kg/m
2#BMI,25.0 kg/m
2), exercising at moderate to vigorous intensity
($150 minutes/week), or AHEI diet score in top two quartiles.
doi:10.1371/journal.pone.0038374.g001
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some [42,43,44], but not all studies [19,45,46,47]. Similarly,
mixed results were observed for overall or central obesity
[43,44,45,46,47,48,49,50], physical activity [19,45,46,48], and
dietary factors, including alcohol [19,45,46,51,52]. These studies
varied in sample size, participants’ characteristics, laboratory
methods for LTL measurement, and instruments for measuring
lifestyle factors. More importantly, since these lifestyle factors are
typically intertwined, mutual confounding by each other may
result in spurious findings. At the same time, given the correlations
among these factors, it is useful to examine the overall lifestyle
pattern, rather than each factor in isolation. Thus far, only one
study examined the joint effects of healthy lifestyle factors on
telomere length. In U.S. men a healthy lifestyle defined by four
low-risk factors (low or no cigarette use, higher fruit and vegetable
intake, lower BMI, and more physical activity) was significantly
associated with higher LTL [19]. To our knowledge, the current
analysis is the first study to evaluate this association explicitly in
women, and we found consistent results indicating that the joint
effects of these factors are stronger than the associations with
individual factors.
Possible mechanisms
In most human adult somatic cells, except human germline and
stem cells, the activity of telomerase is absent or not sufficient to
further elongate telomeric DNA sequence, leading to an average
telomere attrition rate of 15–150 base pairs per cell division [53].
In addition, mounting evidence suggests that inflammation and
oxidative stress, two closely related phenomena, can accelerate
telomere attrition for the entire organism and multiple types of
cells [54]. Telomeres are highly sensitive to the damage rendered
by oxidative stress because of the G-rich nucleotide sequence [55].
Oxidative stress causes single-strand breaks in telomeres and
subsequent telomere shortening, whereas high antioxidative
capacity slows telomere attrition [55,56,57,58]. Similarly, chronic
inflammation promotes telomere shortening, especially in periph-
eral leukocytes, possibly by increasing cell turn-over [59]. In
addition, human studies suggest that increased insulin resistance
may contribute to telomere attrition [49,59]. These mechanisms
likely explain the strong protective effect of healthy lifestyle
behaviors on LTL, given the established protective effects that
these behaviors convey on insulin resistance, chronic inflamma-
tion, and oxidative stress [60].
Strengths and limitations
There are several caveats to the current analyses that deserve
consideration. First, we measured telomere length only in
leukocytes. Whether these associations can be extrapolated to
other tissues is unclear. However, studies have demonstrated
robust correlations between LTL and telomere length in other
tissues, including skin, synovial tissue, vascular wall, and umbilical
artery [61,62,63]. Therefore, LTL may serve as a surrogate
marker for telomere length in other tissues. Second, although the
methods that were used to assess lifestyle and dietary factors have
been validated and the accuracy was proven to be satisfactory in
the NHS cohort, the measurements of lifestyle and dietary factors
are subject to measurement errors. Similarly, our measurement of
LTL had measurement error as well [64]. The use of LTL z score
minimized between-batch variation of telomere length assay,
although the same z score may correspond to different categories
of individual lifestyle factors in each dataset depending on the
dataset-specific distribution of these factors. However, since we
followed strict laboratory protocol ensuring that all of these
measurement errors were not correlated with each other, such
measurement errors were more likely to attenuate true associa-
tions. Third, measurement error of telomere length assay may also
result from DNA oxidation or degradation during long-term
storage. In the NHS, buffy coat fractions were stored at
#2130uC, and extracted DNA samples were stored at #280uC
before telomere length assay. Evidence has suggested that buffy
coats are a reliable source of good-quality DNA for genome-wide
association analysis and other genetic testing after up to 9 years’
storage in a 280uC frozen state [65], although more data are
needed to confirm whether this is also true for telomere length
assays. Nonetheless, when we excluded two studies for which
extracted DNA was stored in freezers #280uC for more than 1
year, we observed similar associations. Fourth, a cross-sectional
study such as this cannot determine a temporal relationship
between lifestyle exposures and telomere length. However, it is
unlikely that telomere length itself would have caused the
participants’ lifestyle behaviors to change, as the participants were
unaware of their telomere status at the time when lifestyle data
were obtained. Fifth, our study participants are primarily
comprised of registered nurses of European ancestry. It is
unknown whether our findings can be generalized to populations
of other ethnicities or with different characteristics that may
modify these associations. More data are warranted to confirm the
current findings. Sixth, to preserve statistical power as much as
possible, we also included cases’ data in the analysis. Because cases
do not represent the NHS population, results are not generalizable
to the whole NHS cohort. Meanwhile, we excluded any
participants with existing major chronic diseases at blood draw
to minimize reverse causation. In addition, when we restricted the
analysis within controls, similar associations were observed,
suggesting that the internal validity was unlikely impaired by
including cases. Lastly, although we adjusted for multiple
confounders in the current analysis, we cannot fully exclude the
possibility that residual confounding may still explain these
findings at least partially.
Our study has several strengths. Due to the low prevalence of
those with multiple low-risk lifestyle factors, a substantial sample
size is required. Our study is one of the largest investigations to
evaluate associations between lifestyle factors and LTL to date.
The homogeneous socio-economic background of our study
participants likely minimized the possibility that this factor or its
correlates confound our observations [48]. Our detailed measure-
ments of lifestyle and dietary factors enabled us to make categories
that were consistent with current guidelines on lifestyle and diet
and can, therefore, be translated easily into public health
messages. Other strengths of the current study included the long
follow-up duration and high participation rate.
Conclusions
As the global population ages, the burden of age-related chronic
disease on the economy, society, and health care systems is
increasing rapidly. Numerous prior studies have demonstrated that
the risk of developing diabetes, cardiovascular disease, cancer, and
premature death is substantially lower among those who adhere to
a healthy lifestyle pattern [11,12,13,14,15,16,17,18]. Our analyses
further document that a healthy lifestyle is associated with longer
leukocyte telomere length, a marker of biological aging that may
be a common mechanism underlying the etiology of multiple age-
related diseases.
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